期刊文献+

心脏磁共振显像技术对存活心肌的评估与临床应用 被引量:2

Cardiac Magnetic Resonance Imaging Assessment and Clinical Use of Myocardial Viability
下载PDF
导出
摘要 存活心肌的评估对冠心病的预后及治疗方案有着重要的意义,心脏磁共振成像技术对存活心肌的检出具有较强的应用价值。其检测存活心肌的手段包括:静息心脏磁共振测量室壁厚度改变,多巴酚丁胺负荷磁共振成像评估心肌收缩功能储备,对比增强心脏磁共振以及磁共振波谱来评估存活心肌,延迟增强技术对心内膜下心肌梗死及非透壁心肌梗死的诊断优势明显。3.0T心脏核磁共振的应用成倍地增加信号噪声比和对比剂噪声比,进一步提高了诊断的准确率。心肌磁共振是一项安全、无创、无放射性的检查,但其在实际应用中亦存在一些问题。 Assessment of myocardial viability is pivotal to the prognosis and treatment of coronary artery disease(CAD) .Cardiac magnetic resonance(CMR) imaging is practically valuable in detecting viable myocardial muscles with resting CMR to detect the change of ventricular thickening,with dobutamine CMR to evaluate myocardial contractile reserve,and with contrast-enhanced CMR and magnetic resonance spectroscopy to determine myocardial viability.Late gadolinium enhancement CMR imaging is obviously advantageous in the diagnosis of subendocardial and nontransmural infarction.Application of 3.0T CMR multiplies the signal-to-noise ratio( SNR) and contrast-to-noise ratio( CNR) ,further improving the accuracy of diagnosis.It is a safe,noninvasive and nonradioactive examination.Whereas there are some problems in practical application.
作者 蓝明 何青
出处 《医学综述》 2010年第14期2222-2224,共3页 Medical Recapitulate
关键词 存活心肌 心脏磁共振 对比增强 Myocardial viability Cardiac magnetic resonance Contrast enhancement
  • 相关文献

参考文献1

同被引文献42

  • 1顾颖莉,朱汉威.环磷酰胺心脏毒性作用的研究进展[J].上海第二医科大学学报,2004,24(9):772-774. 被引量:14
  • 2杨金巧,葛鹏磊,贺萍,朱红亚.赫赛汀联合泰素帝治疗炎性乳腺癌1例报告[J].四川大学学报(医学版),2006,37(6):954-954. 被引量:8
  • 3董建红,张燕,苏喜改,吴琳.参麦注射液联合香丹注射液预防蒽环类化疗药物所致心脏毒性的临床观察[J].现代中西医结合杂志,2007,16(2):177-178. 被引量:13
  • 4Pizzino F,Vizzari G,Bomzer CA,et al. Diagnosis of chemotherapy-induced cardiotoxicity [J]. J Patient Cent Res Rev,2014,1(3) : 121-127.
  • 5Vejpongsa P,Yeh ET. Prevention of anthracycline-in- duced cardiotoxicity :challenges and opportunities [J]. J Am Coil Cardiol, 2014,64(9) : 938-945.
  • 6Patan S. Cardiotoxicity:anthracyelines and long term can- cer suryvo[J]. IntJ Cardiol,2014,176(3): 13267- 1328.
  • 7Katayama M, Imai Y, Hashimoto H, et al. Fulminant fatal cardiotoxicity following cyclophosphamide therapy[J]. J Cardiol, 2009,54(2) : 330-334.
  • 8Trippett TM,Schwartz CL,Guillerman RP,et al. Ifos- famide and vinorelbine is an effective reinduction regi- men in children with refractory/relapsed Hodgkin lym- phoma,AHOD00P1 :a children' s oncology group report [J]. Pediatr Blood Cancer, 2015,62(1) : 60-64.
  • 9Demkow U ,Stelmaszczyk-Emmel A. Cardiotoxicity of cis- platin-based chemotherapy in advanced non-small cell lung cancer patients[J]. Respir Physiol Neurobiol,2013, 187(1) : 64-67.
  • 10Shah K,Gupta S,Ghosh J,et al. Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma:a case report and review of litera- ture[J]. J Cancer Res Ther, 2012,8(3):442-444.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部